State Street Corp Pacira Bio Sciences, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 2,014,012 shares of PCRX stock, worth $34.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,014,012

Previous 1,903,850 5.79%

Holding current value

$34.3 Million

Previous $54.5 Million 44.32%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $1.29 Million - $3.14 Million	110,162 Added 5.79%	2,014,012 $30.3 Million
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $6,069 - $7,499	238 Added 0.01%	1,903,850 $54.5 Million
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $901,524 - $1.15 Million	-32,546 Reduced 1.68%	1,903,612 $55.6 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $3.97 Million - $5.18 Million	150,919 Added 8.45%	1,936,158 $65.3 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $2.06 Million - $2.69 Million	67,093 Added 3.9%	1,785,239 $54.8 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $1.29 Million - $1.7 Million	35,813 Added 2.13%	1,718,146 $68.8 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $2.37 Million - $2.9 Million	66,767 Added 4.13%	1,682,333 $68.7 Million
Q4 2022 Feb 14, 2023	SELL	$38.19 - $57.45 $3.21 Million - $4.83 Million	-84,062 Reduced 4.95%	1,615,566 $62.4 Million
Q3 2022 Nov 15, 2022	BUY	$51.24 - $58.89 $2.31 Million - $2.66 Million	45,155 Added 2.73%	1,699,628 $90.4 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $2.51 Million - $3.98 Million	48,715 Added 3.03%	1,654,473 $96.5 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $4.55 Million - $5.79 Million	75,757 Added 4.95%	1,605,758 $123 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $3.25 Million - $4.22 Million	67,824 Added 4.64%	1,530,001 $92.1 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $808,125 - $906,627	-14,790 Reduced 1.0%	1,462,177 $81.9 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $2.67 Million - $3.16 Million	45,127 Added 3.15%	1,476,967 $89.6 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $485,511 - $645,220	8,186 Added 0.57%	1,431,840 $100 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $542,249 - $711,897	10,744 Added 0.76%	1,423,654 $85.2 Million
Q3 2020 Nov 10, 2020	SELL	$51.97 - $63.0 $4.02 Million - $4.87 Million	-77,274 Reduced 5.19%	1,412,910 $84.9 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $2.66 Million - $4.54 Million	86,525 Added 6.16%	1,490,184 $78.2 Million
Q1 2020 May 11, 2020	BUY	$28.4 - $50.7 $39.9 Million - $71.2 Million	1,403,659 New	1,403,659 $47.1 Million

Others Institutions Holding PCRX

# of Institutions

264

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $780M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Pacira Bio Sciences, Inc. Transaction History